高流动性群体的第1框成为喘治疗的治疗目标
Qianni Yang1,2, Min Li1, Yunjiao Hou1
1Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Immunity, inflammation and disease
|December 29, 2023
概括
高流动性组盒1 (HMGB1) 是一种核蛋白,在细胞外时作为炎症因子. HMGB1涉及喘病原体,并具有潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 高流动性组盒1 (HMGB1) 是一个参与DNA过程和细胞应激的核蛋白.
- 细胞外HMGB1作为一种强大的炎症调解剂,触发免疫反应.
- 包括HMGB1/RAGE和HMGB1/NF-κB在内的HMGB1信号通路在炎症中至关重要.
研究的目的:
- 阐明HMGB1在炎症过程中的作用.
- 为了调查HMGB1在喘病变的参与.
- 确定HMGB1作为喘潜在的治疗点.
主要方法:
- 检查HMGB的细胞内和细胞外功能1.1.
- 分析HMGB1在各种信号通路中的作用 (例如,HMGB1/RAGE,HMGB1/NF-κB,HMGB1/JAK/STAT).
- 检查HMGB1在与喘相关的信号通路中的参与 (例如,HMGB1/TLR4/NF-κB,HMGB1/RAGE,HMGB1/TGF-β).
主要成果:
- HMGB1调节细胞内功能,包括DNA转录,复制和修复.
- 细胞外HMGB1作为一种促炎细胞因子,启动炎症和免疫反应.
- HMGB1调解了关键的信号通路,与喘发育有关.
结论:
- HMGB1在调解炎症和免疫反应方面发挥着重要作用.
- HMGB1与喘的发病过程密切相关.
- 向HMGB1为喘治疗提供了一个有前途的治疗策略.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
301
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
301
01:19Antiasthma Drugs: Leukotriene Modifiers
306
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
306
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
257
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
257
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
307
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
307